• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童EB病毒相关噬血细胞性淋巴组织细胞增生症的临床特征及预后因素分析

Analysis of clinical characteristics and prognostic factors associated with EBV-associated HLH in children.

作者信息

Qiu Kun-Yin, Guo Shu-Yi, Zeng Yang-Hui, Liao Xiong-Yu, Lin Shao-Fen, Fang Jian-Pei, Zhou Dun-Hua

机构信息

Children's Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.

出版信息

Hematology. 2022 Dec;27(1):874-880. doi: 10.1080/16078454.2022.2109328.

DOI:10.1080/16078454.2022.2109328
PMID:35950974
Abstract

Purpose Our aim is to analyze the clinical characteristics and prognostic factors of Epstein-Barr (EB) virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in children. Methods Children with newly diagnosed HLH were retrospectively analyzed. Results Finally, a total of 95 children with HLH were enrolled in this study, including 43 (45.3%) with EBV-HLH and 52 (54.7%) with non-EBV-HLH. Laboratory tests showed that the levels of absolute neutrophil count (ANC) decrease ( = 0.031) and triglycerides (TG) increase ( = 0.036) in the EBV-HLH group were statistically significant compared with those in the non-EBV-HLH group, respectively. We found that the remission rate during induction period in the EBV-HLH group and non-EBV-HLH group was 75.8% and 89.3%, respectively. The correlation analysis showed that the elevated degree of total bilirubin (TBIL) ( = 0.042), triglyceride (TG) ( = 0.009), serum ferritin (SF) ( = 0.008) and interleukin-8 (IL-8) ( = 0.004) were related with the remission rate during induction in the EBV-HLH group. Further univariate analysis showed that the elevated degree of TBIL ( = 0.048) and TG ( = 0.019) were significant risk factors for the remission rate during induction in the EBV-HLH group. In the multivariate analysis, we observed that there was statistical significance for the degree of TG elevation ( = 0.015) between the two groups. The correlation analysis showed that the elevated degree of TBIL ( = 0.030), the elevated degree of SF ( = 0.020) and the elevated degree of interleukin-6 ( = 0.010) were related to the induction mortality of children with EBV-HLH. Conclusion TBIL and TG are valid indicators to assess the efficacy and prognosis of EVBHLH among children in induction period.

摘要

目的 我们的目的是分析儿童爱泼斯坦-巴尔(EB)病毒相关噬血细胞性淋巴组织细胞增生症(EBV-HLH)的临床特征和预后因素。方法 对新诊断的HLH患儿进行回顾性分析。结果 最终,本研究共纳入95例HLH患儿,其中43例(45.3%)为EBV-HLH,52例(54.7%)为非EBV-HLH。实验室检查显示,与非EBV-HLH组相比,EBV-HLH组的绝对中性粒细胞计数(ANC)水平降低(P = 0.031)和甘油三酯(TG)水平升高(P = 0.036)具有统计学意义。我们发现,EBV-HLH组和非EBV-HLH组诱导期的缓解率分别为75.8%和89.3%。相关性分析显示,EBV-HLH组总胆红素(TBIL)升高程度(P = 0.042)、甘油三酯(TG)升高程度(P = 0.009)、血清铁蛋白(SF)升高程度(P = 0.008)和白细胞介素-8(IL-8)升高程度(P = 0.004)与诱导期缓解率相关。进一步单因素分析显示,TBIL升高程度(P = 0.048)和TG升高程度(P = 0.019)是EBV-HLH组诱导期缓解率的显著危险因素。多因素分析中,我们观察到两组间TG升高程度有统计学意义(P = 0.015)。相关性分析显示,TBIL升高程度(P = 0.030)、SF升高程度(P = 0.020)和白细胞介素-6升高程度(P = 0.010)与EBV-HLH患儿的诱导期死亡率相关。结论 TBIL和TG是评估儿童EBV-HLH诱导期疗效和预后的有效指标。

相似文献

1
Analysis of clinical characteristics and prognostic factors associated with EBV-associated HLH in children.儿童EB病毒相关噬血细胞性淋巴组织细胞增生症的临床特征及预后因素分析
Hematology. 2022 Dec;27(1):874-880. doi: 10.1080/16078454.2022.2109328.
2
Clinical laboratory Analysis of EB Virus Associated Hemophagocytic Lymphohistiocytosis in Children.儿童 EB 病毒相关性噬血细胞性淋巴组织细胞增生症的临床实验室分析。
Altern Ther Health Med. 2024 May;30(5):148-154.
3
[Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].儿童Epstein-Barr病毒相关噬血细胞性淋巴组织细胞增生症的临床分析及随访研究
Zhonghua Er Ke Za Zhi. 2010 Feb;48(2):121-6.
4
[Comparative Analysis of Primary and Reactivated EB Virus Infection Associated Hemophagocytic Lymphohistiocytosis].原发性与复发性EB病毒感染相关噬血细胞性淋巴组织细胞增生症的比较分析
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Apr;31(2):575-580. doi: 10.19746/j.cnki.issn.1009-2137.2023.02.038.
5
[Therapeutic Effect of PE+CRRT Combined with Chemotherapy on Children with Severe EBV-HLH and Non-EBV-HLH].PE+CRRT联合化疗对儿童重症EBV-HLH和非EBV-HLH的治疗效果
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Feb;29(1):259-264. doi: 10.19746/j.cnki.issn.1009-2137.2021.01.043.
6
Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.儿童 Epstein-Barr 病毒相关性噬血细胞性淋巴组织细胞增生症的预后因素:日本组织细胞学会报告。
Pediatr Blood Cancer. 2014 Jul;61(7):1257-62. doi: 10.1002/pbc.24980. Epub 2014 Feb 17.
7
Clinical utility of plasma Epstein-Barr virus DNA monitoring in pediatric Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: a Chinese retrospective observational study.血浆 Epstein-Barr 病毒 DNA 监测在儿科 EBV 相关噬血细胞性淋巴组织细胞增生症中的临床应用:一项中国回顾性观察研究。
Ital J Pediatr. 2024 Jul 30;50(1):139. doi: 10.1186/s13052-024-01689-8.
8
Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection.儿童内脏利什曼病和 Epstein-Barr 病毒感染患者中的继发性噬血细胞性淋巴组织细胞增生症。
Ann Hematol. 2024 May;103(5):1541-1547. doi: 10.1007/s00277-024-05695-y. Epub 2024 Mar 12.
9
Epstein-Barr virus central nervous system involvement in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.爱泼斯坦-巴尔病毒相关噬血细胞性淋巴组织细胞增生症中的爱泼斯坦-巴尔病毒中枢神经系统受累情况
Ann Hematol. 2022 Nov;101(11):2471-2476. doi: 10.1007/s00277-022-04957-x. Epub 2022 Sep 7.
10
Specific cytokine patterns in Epstein-Barr virusassociated hemophagocytic lymphohistiocytosis compared to Kawasaki disease in children.儿童 EBV 相关性噬血细胞性淋巴组织细胞增生症与川崎病的特定细胞因子模式比较。
Pediatr Hematol Oncol. 2023;40(6):529-538. doi: 10.1080/08880018.2023.2186555. Epub 2023 May 13.

引用本文的文献

1
Hemophagocytic Lymphohistiocytosis: An 18-Year-Long Retrospective Single-Center Study.噬血细胞性淋巴组织细胞增生症:一项长达18年的回顾性单中心研究。
Cureus. 2025 Jul 26;17(7):e88831. doi: 10.7759/cureus.88831. eCollection 2025 Jul.
2
Clinical significance and different strategies for re-elevation of plasma EBV-DNA during treatment in pediatric EBV-associated hemophagocytic lymphohistiocytosis.儿童 EBV 相关噬血细胞性淋巴组织细胞增生症治疗过程中血浆 EBV-DNA 再次升高的临床意义及不同策略。
J Pediatr (Rio J). 2024 Sep-Oct;100(5):505-511. doi: 10.1016/j.jped.2024.03.006. Epub 2024 Apr 8.